Masahiko Mihara
Product Research Department
Fuji-Gotemba Research Laboratories
Chugai Pharmaceutical Co. Ltd.
Komakado 1-Chome
Japan
Name/email consistency: high
- Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti-interluekin-6 receptor antibody. Mihara, M., Ohsugi, Y., Kishimoto, T. Biofactors (2009)
- Different effects of high molecular weight sodium hyaluronate and NSAID on the progression of the cartilage degeneration in rabbit OA model. Mihara, M., Higo, S., Uchiyama, Y., Tanabe, K., Saito, K. Osteoarthr. Cartil. (2007)
- The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody. Mihara, M., Nishimoto, N., Ohsugi, Y. Expert. Opin. Biol. Ther (2005)
- Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. Mihara, M., Kasutani, K., Okazaki, M., Nakamura, A., Kawai, S., Sugimoto, M., Matsumoto, Y., Ohsugi, Y. Int. Immunopharmacol. (2005)
- Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis. Mihara, M., Shiina, M., Nishimoto, N., Yoshizaki, K., Kishimoto, T., Akamatsu, K. J. Rheumatol. (2004)
- Influences of anti-mouse interleukin-6 receptor antibody on immune responses in mice. Mihara, M., Nishimoto, N., Yoshizaki, K., Suzuki, T. Immunol. Lett. (2002)